Transforming Breast Cancer Care with VM-1 Visual Tumor Marker

At VizMark, we’re dedicated to improving patient outcomes and empowering medical professionals with technology that makes a difference.

Breast Cancer Insights

Breast cancer is the most commonly diagnosed cancer in women worldwide

Breast Cancer Insights

Up to 32% of Women may be considered high risk

Breast Cancer Insights

MRI is the most accurate screening for women in a high risk category

Breast Cancer Insights

Currently over 4 million breast cancers survivors in the United States

Breast Cancer Insights

1 in 8 women will be diagnosed with breast cancer in her lifetime

We asked a simple question:

“Why can’t tumor markers work better for every patient, every imaging system, and every tumor type?”

Meet VM-1

A Breakthrough in Tumor Markers

Cap
The cap is PEEK, infused with Carbon, which adheres to tissue allowing no movement of the marker.
Vial
The vial is PEEK, infused with Barium Sulfate, which enhances visibility under:
X-ray
Tomography
Mammography
CT
The vial is filled with a contrast agent, which enhances visibility under MRI.
An air pocket inside the vial enhances visibility under ultrasound.
with VM-1

Why Choose VM-1?

Unlike traditional markers, VM-1 isn’t just about identification during procedures. It provides long-term solutions for post-biopsy care, ensuring lifetime visibility and reliability for high-risk patients, including those with dense breast tissue.

VM-1 In Dense Breast Tissue Mammogram view

VM-1 in a Benign Fibroadenoma Ultrasound view

Clearly Visible

Compatible with Mammography, X-Ray Ultrasound and MRI.

Safe for Patients

Non-metallic, allergy-free materials for peace of mind.

Unobstructed Imaging

Clear tumor visualization with no masking or artifacts.

Reliable for Life

Designed to remain visible across imaging systems permanently.

Without VM-1

VM1 Designed to Avoid Interference Under Magnetic Imaging

VM-1 allows physicians to mark smaller tumors with out concern of actual marker blocking or obstructing the tumor.

Eliminating voids in breast tissue markers is crucial for radiotherapy and surgical planning with artifact variability depending on breast marker type, field strength, and sequence. Marker-related artifacts can hinder accurate interpretation of scams, visibility of small lesions and appropriate treatment planning.

VM-1 allows physician's to mark smaller tumors reducing obstructions of the tumor

Independent of Imaging Modality

VM-1 ensures crystal-clear imaging across X-ray, MRI, Mammography, Ultrasound, CT, and PET scans, enabling accurate diagnosis and treatment planning.

Minimal Interference

Unlike traditional metallic markers, VM-1 does not obstruct surrounding tissue, ensuring accurate and detailed imaging.

Precision in Dense Breast Tissue

Even in complex cases like dense tissue (common in 40% of women), VM-1 provides exceptional visibility.

Permanent Reliability

VM-1 remains visible throughout the patient’s lifetime, providing confidence for long-term care.

Safe and Easy to Use

Non-metallic, allergy-safe materials and a versatile design make VM-1 the trusted choice for both routine and complex cases.

How VM-1 Benefits Patients

Safety and Comfort

VM-1 is crafted from non-metallic, biocompatible materials to ensure safety and comfort, eliminating allergy risks associated with traditional markers.

Reliable Monitoring

Patients and their care teams can trust consistent imaging results, enabling precise treatment planning and follow-up care.

Better Outcomes

VM-1 supports less invasive, more effective care by reducing risks like allergic reactions, migration, or imaging inaccuracies.

Lasting Confidence

With VM-1, patients know their biopsy site will remain identifiable for future imaging, reducing uncertainties and ensuring ongoing care quality.

Transforming Breast Cancer Care with VM-1 Smart Visual Markers

At VizMark, we’re dedicated to improving patient outcomes and empowering medical professionals with technology that makes a difference.

Join the Revolution in Women’s Health

As VM-1 sets a new standard for post-biopsy care, we’re not just improving technology—we’re improving lives.

About VizMark

Our team, led by radiologist and women’s health advocate Dr. Michael T. Nelson, created VM-1 improve imaging under MRI necessary for high risk patients. Through years of research and collaboration, we’ve designed a marker that eliminates the challenges of traditional solutions, offering better outcomes for patients and providers alike.

Dr. Michael Nelson
Founder and primary inventor, Dr. Nelson is a Board-Certified Radiologist, former U.S. Navy Flight Surgeon, and Professor of Radiology at the University of Minnesota. A leader in Mammography, Interventional Radiology, and Women’s Health, he co-founded the Jane Brattain Breast Center at Park Nicollet Medical Center.

Dr. Michael Nelson

Founder, Chief Medical Officer, and radiology expert

Kim Nelson
Accomplished senior executive and board member with 30+ years in high-tech, leading business growth, revenue expansion, and successful exits, including roles at Oracle and Primus Knowledge (IPO).

Kim Nelson

CEO with a proven track record of driving innovation

Tom Murphy
With 30+ years in medical device sales, operations, and management, Mr. Murphy has deep expertise in the tumor marker space, leading operations and sales at Mermaid Medical, Argon Medical, and Angiotech.

Tom Murphy

VP of Operations, tumor marker specialist

Steve Karel
A biotech senior executive with startup experience, Mr. Karel has held roles as CEO, CFO, and SVP of Business Development. He brings expertise in finance, fundraising, corporate development, and R&D, strengthening VizMark’s operations and growth.

Steve Karel

CFO with deep expertise in medical finance